The fact that PRKRA/CHROMR ratio, but not the genes separately, had an effect on survival of glioblastoma patients, suggests that CHROMR may indeed have some NAT-associated interaction with the overlapped PRKRA gene in glioblastoma, but not low-grade glioma. The gene discussed is PRKRA; the disease is central nervous system cancer.